Summary
Updated Aug 31, 2026
Edward J. Dulac III is EVP, Chief Financial Officer of Intellia Therapeutics, Inc. (NTLA). 5 SEC Form 4 filings on record going back to 2025, most recently on 24 July 2026. Most recent open-market trade: sold $91K of NTLA on 24 July 2026. Lifetime open-market sales: $339K.
Recent Transactions
5Every recent SEC Form 4 transaction Edward J. Dulac III has reported, most recent first.
Trading Pattern
InsiderAlpha's records for Edward J. Dulac III go back to 2025: 5 primary Form 4 filings, an average of 2.5 per year. 1 recorded transaction carries a Rule 10b5-1 flag, meaning it was pre-scheduled under a written trading plan rather than discretionary.
Other Insiders Active in the Same Stocks
Insiders who reported open-market trades in the last 12 months at the companies Edward J. Dulac III files at. Multiple unrelated insiders buying the same stock within a short window, cluster buying, has historically been one of the strongest Form 4 signals.
- John M. Leonard - $1.44M of NTLA open-market activity in the last 12 months
- Fred E. Cohen - $1.40M of NTLA open-market activity in the last 12 months
- James Basta - $112K of NTLA open-market activity in the last 12 months
- David Lebwohl - $110K of NTLA open-market activity in the last 12 months
- Michael P. Dube - $104K of NTLA open-market activity in the last 12 months
- Eliana Clark - $96K of NTLA open-market activity in the last 12 months
More Notable Insiders
Other corporate insiders with significant SEC Form 4 track records on InsiderAlpha:
Frequently Asked Questions
Who is Edward J. Dulac III?
Edward J. Dulac III is a corporate insider, tracked as EVP, Chief Financial Officer of Intellia Therapeutics, Inc. (NTLA). InsiderAlpha holds 5 primary Form 4 filings for them, the earliest from 2025, updated as new SEC EDGAR filings are processed.
How many SEC Form 4 filings has Edward J. Dulac III submitted recently?
2 primary Form 4 filings in the last 90 days, covering 1 company.
Has Edward J. Dulac III been buying or selling stock?
Recorded transactions: 0 open-market purchases and 4 open-market sales ($339K) across all tracked filings.
Where can I see all of Edward J. Dulac III's SEC filings?
All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.
Learn More
Follow Edward J. Dulac III and every insider like them
A free account opens the full scored daily plan and every past day, a watchlist for any ticker, and 3 months of price history on every company page. No card.
Free plan available · Paid plans start with a 7-day free trial